Neuroone Medical Technologies (NMTC) Return on Assets (2016 - 2025)
Historic Return on Assets for Neuroone Medical Technologies (NMTC) over the last 11 years, with Q4 2025 value amounting to 0.71%.
- Neuroone Medical Technologies' Return on Assets rose 5100.0% to 0.71% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.71%, marking a year-over-year increase of 5100.0%. This contributed to the annual value of 0.45% for FY2025, which is 13800.0% up from last year.
- As of Q4 2025, Neuroone Medical Technologies' Return on Assets stood at 0.71%, which was up 5100.0% from 0.33% recorded in Q3 2025.
- Neuroone Medical Technologies' 5-year Return on Assets high stood at 0.33% for Q3 2025, and its period low was 2.4% during Q3 2024.
- In the last 5 years, Neuroone Medical Technologies' Return on Assets had a median value of 1.0% in 2022 and averaged 1.19%.
- As far as peak fluctuations go, Neuroone Medical Technologies' Return on Assets crashed by -11700bps in 2024, and later surged by 20600bps in 2025.
- Quarter analysis of 5 years shows Neuroone Medical Technologies' Return on Assets stood at 0.86% in 2021, then rose by 8bps to 0.79% in 2022, then tumbled by -144bps to 1.94% in 2023, then surged by 37bps to 1.21% in 2024, then soared by 42bps to 0.71% in 2025.
- Its last three reported values are 0.71% in Q4 2025, 0.33% for Q3 2025, and 0.7% during Q2 2025.